Trophoblast 'pseudo-tumorigenesis': Significance and contributory factors

Reproductive Biology and Endocrinology

Volumn 2, Issue , 2004, Pages

  Soundararajan, Rama ^a   Rao, A Jagannadha ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CATHEPSIN; CHORIONIC GONADOTROPIN; COLONY STIMULATING FACTOR RECEPTOR; DECAY ACCELERATING FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; INTEGRIN; INTERLEUKIN 2; MATRIX METALLOPROTEINASE; MYC PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; SCLEROPROTEIN; SERINE PROTEINASE; SOMATOMEDIN BINDING PROTEIN 1; TELOMERASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; APOPTOSIS; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL TYPE; CHORIOCARCINOMA; CYTOTROPHOBLAST; EMBRYO; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; FETUS; HUMAN; INTRAUTERINE GROWTH RETARDATION; METASTASIS; MISSED ABORTION; PHENOTYPE; PLACENTA; PREECLAMPSIA; PREGNANCY DISORDER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTO ONCOGENE; REGULATORY MECHANISM; REVIEW; TROPHOBLASTIC TUMOR; TUMOR CELL; CANCER INVASION; CELL DIVISION; CELL MOTION; CYTOLOGY; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; TROPHOBLAST;

CELL DIVISION; CELL MOVEMENT; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; TROPHOBLASTS;

EID: 4344665021     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-2-15     Document Type: Review

References (106)

1. Tuttle SE, O'Toole RV, O'Shaughnessy RW, Zuspan FP: Immunochemical evaluation of human placental implantation: an initial study. Am J Obstet Gynecol 1985, 153:239-244.
2. Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Yang ZG, Tarpey J, Damsky CH: Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol 1989, 109:891-902.
3. Emonard H, Christiane Y, Smet M, Grimaud JA, Foidart JM: Type IV and interstitial collagenolytic activities in normal and malignant trophoblast cells are specifically regulated by the ECM. Invasion Metastasis 1990, 10:170-177.
4. Kliman HJ, Feinberg RF: Human trophoblast-extracellular matrix (ECM) interactions in vitro: ECM thickness modulates morphology and proteolytic activity. Proc Natl Acad Sci USA 1990, 87:3057-3061.
5. Fisher SJ, Leitch MS, Kantor MS, Basbaum CB, Kramer RH: Degradation of extracellular matrix by the trophoblastic cells of first-trimester placentas. J Cell Biochem 1985, 27:31-41.
6. Bischof P, Martelli M: Proteolysis in the penetration phase of the implantation process. Placenta 1992, 13:17-24.
7. Bischof P, Martelli M, Campana A, Itoh Y, Ogata Y, Nagase H: Importance of matrix metalloproteinases in human trophoblast invasion. Early Pregnancy 1995, 1:263-269.
8. Nagase H, Ogata Y, Suzuki K, Enghild JI, Salveson G: Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans 1991, 19:715-718.
9. Puistola U, Ronnberg L, Martikainen H, Turpeenniemi-Hujanen T: The human embryo produces basement membrane collagen (type IV collagen) degrading protease activity. Hum Reprod 1989, 4:309-311.
10. Murray MJ, Lessey BA: Embryo implantation and tumor metastasis: Common pathways of invasion and angiogenesis. Semin Reprod Endocrinol 1999, 17:275-290.
11. Bernhard EJ, Gruber SB, Muschel RJ: Direct evidence linking expression of matrix metalloproteinase-9 (92 kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 1994, 91:4293-4297.
12. DeClarck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992, 52:701-708
13. Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: requirement for a proteolytic cascade. Cell 1986, 47:487-498.
14. Hicks NJ, Ward RV, Reynolds JJ: A fibrosarcoma model derived from mouse embryo cells: growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumor cell lines. Int J Cancer 1984, 33:835-844.
15. Yagel S, Parhar RS, Jeffrey JJ, Lala PK: Normal non-metastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol 1988, 136:455-462.
16. Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stettler-Stevenson WG, Lala PK: Resistance of malignant trophoblastic cells to both the anti-proliferative and anti-invasive effects of TGFΒ. Exp Cell Res 1994, 214:93-99.
17. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ: 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991, 113:437-449.
18. Cross JC, Werb Z, Fisher SJ: Implantation and the placenta: key pieces of the development puzzle. Science 1994, 266:1508-1518.
19. Zini JM, Murray SC, Graham CH, Lala PK, Kariko K, Barnathan ES, Mazar A, Herkin J, Cines DB, McCrae KR: Characterization of urokinase receptor expression by human placental trophoblasts. Blood 1992, 79:2917-2929.
20. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Dano K, Appella E, Blasi F: Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin-dependent proteolysis. EMBO J 1990, 9:467-474.
21. O'Brien PJ, Koi H, Parry S, Brass LF, Strauss 3rd JF, Wang LP, Tomaszewski JE, Christenson LK: Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro. Am J Pathol 2003, 163:1245-1254.
22. Heino J: Integrin-type extracellular matrix receptors in cancer and inflammation. Ann Med 1993, 25:335-342.
23. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ: Integrin switching regulates normal trophoblast invasion. Development 1994, 120:3657-3666.
24. Bischof P, Campana A: Trophoblast differentiation and invasion: its significance for human embryo implantation. Early Pregnancy 1997, 3:81-95.
25. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR: IGFBP-1 stimulates cell migration and binds to the α5β1 integrin by means of its ARG-GLY-ASP sequence. Proc Natl Acad Sci USA 1993, 90:10553-10557.
26. Danen EH, Ten Berge PJ, Van Muijen GN, Van't Hof-Grootenboer AE, Brocker EB, Ruiter DJ: Emergence of α5β1 fibronectin- and αvβ3 vitronectin-receptor expression in melanocytic tumor progression. Histopathology 1994, 24:249-256.
27. Han VKM, Bassett N, Walton J, Challis JRG: The expression of IGF and IGFBP genes in the human placenta and membranes: evidence for IGF-IGFBP interaction at the feto-maternal interface. J Clin Endocrinol Metab 1996, 81:2680-2693.
28. Lavelle F, Riou JF, Laoui A, Mailliet P: Telomerase: a therapeutic target for the third millennium? Crit Rev Oncol Hematol 2000, 34:111-126.
29. Watson JD: Origin of concatemeric T7 DNA. Nat New Biol 1972, 239:197-201.
30. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
31. Wright WE, Braiskyte D, Piatyszek MA, Shay JW: Experimental elongation of telomeres in immortal human cells extends the lifespan of immortal normal hybrids. EMBO J 1996, 15:1734-1741.
32. Kipling D, Wynford-Thomas D, Jones CJ, Akbar A, Aspinall R, Bacchetti S, Blasco MA, Broccoli D, DePinho RA, Edwards DR, Effros RB, Harley CB, Lansdorp PM, Linskens MH, Prowse KR, Newbold RF, Olovnikov AM, Parkinson EK, Pawalec G, Ponten J, Shall S, Zijlmans M, Faragher RG: Telomere-dependent senescence. Nat Biotechnol 1999, 17:313-314.
33. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-413.
34. Harley CB, Kim NW: Important advances in oncology. In Telomerase and cancer (Edited by: De Vita VT, Hellman S, Rosenberg SA). Philadelphia: Lippincott 1996, 57-67.
35. Kyo S, Takakura M, Inoue M: Telomerase activity in cancer as a diagnostic and therapeutic target. Histol Histopathol 2000, 15:813-824.
36. Rama S, Suresh Y, Rao AJ: Regulation of telomerase during human trophoblast differentiation: A role for TGF β1. Mol Cell Endocrinol 2001, 182:233-248.
37. Chen RJ, Chu CT, Huang SC, Chow SN, Hsieh CY: Telomerase activity in gestational trophoblastic disease and placental tissue from early and late human pregnancies. Hum Reprod 2002, 17:463-468.
38. Beer AF, Billingham RE: Host responses to intrauterine tissue, cellular and fetal allografts. J Reprod Fertil Suppl 1974, 21:59-88.
39. Clemens LE, Siiteri PK, Stites DP: Mechanism of immuno-suppression of progesterone on maternal lymphocyte activation during pregnancy. J Immunol 1979, 122:1978-1985.
40. Lawrence R, Church JA, Richards W, Borzy M: Immunological mechanisms in the maintenance of pregnancy. Ann Allergy 1980, 44:166-173.
41. Peyman JA: Mammalian expression cloning of two human trophoblast suppressors of MHC genes. Am J Reprod Immunol 2001, 45:382-392.
42. Das SK, Flanders KC, Andrews GK, Dey SK: Expression of TGF β-isoforms (β2 and β3) in the mouse uterus: Analysis of the peri-implantation period and effects of ovarian steroids. Endocrinol 1992, 130:3459-3466.
43. Wood GW: Is restricted antigen presentation the explanation for fetal allograft survival? Immunol Today 1994, 15:15-18.
44. Moulton BC: Transforming Growth Factor β-stimulated endometrial stromal apoptosis in vitro. Endocrinol 1993, 134:1055-1060.
45. Chaouat G, Meliani AA, Martal J, Raghupathy R, Elliot J, Mosmann T, Wegmann TG: IL-10 prevents naturally occurring fetal loss in the CBAXDBA/2 mating combination and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 1995, 154:4261-4268.
46. Uckan D, Steele A, Cherry Wang BY, Chamizo W, Koutsonikolis A, Barness EG, Good RA: Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997, 3:655-662.
47. Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A: Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J Immunol 2003, 171:2305-2313.
48. Purcell DF, McKenzie IF, Lubin DM, Johnson PM, Atkinson JP, Oglesby TJ, Deacon NJ: The human cell surface glycoproteins HuLy-m5, membrane cofactor protein (MCP) of the complement system, and trophoblast-leukocyte common (TLX) antigen, are CD46. Immunology 1990, 70:155-161.
49. Holmes CH, Simpson KL, Wainwright SD, Tate CG, Houlihan JM, Sawyer IH, Rogers IP, Spring FA, Anstee DJ, Tanner MJ: Preferential expression of the complement regulatory protein, decay-accelerating factor, at the feto-maternal interface during pregnancy. J Immunol 1990, 144:3099-4105.
50. Holmes CH, Simpson KL: Complement and pregnancy: new insights into the immunobiology of the feto maternal relationship. Baillieres Clin Obstet Gynaecol 1992, 6:439-460.
51. Beer AE, Sio JO: Placenta as an immunological barrier. Biol Reprod 1982, 26:15-27.
52. Hunt JS, Orr HT: HLA and maternal-fetal recognition. FASEB J 1992, 6:2344-2348.
53. Peyman JA: Repression of MHC genes by a human trophoblast RNA. Biol Reprod 1999, 60:23-31
54. Enders AC: Trophoblast-uterine interactions in the first days of implantation: models for the study of implantation events in the human. Semin Reprod Med 2000, 18:255-263.
55. Lefebvre S, Berrih-Aknin S, Adrian F, Moreau P, Poea S, Gourand L, Dausset J, Carosella ED, Paul P: A specific IFN-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor-1 and mediates enhancement of this non-classical Class-I gene by IFNβ. J Biol Chem 2001, 276:6133-6139.
56. Momburg F, Ziegler A, Harpprecht J, Moller P, Mold enhauen G, Hammerling GJ: Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J Immunol 1989, 142:352-358.
57. Zhou Y, Damsky CH, Fisher SJ: Pre-eclampsia is associated with a failure of human cytotrophoblasts to mimic a vascular phenotype: one cause of defective endovascular invasion in this syndrome? J Clin Invest 1997, 99:2152-2164.
58. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH: Human cytotrophoblasts adopt a vascular phenotype as they differentiate-A strategy for successful endovascular invasion? J Clin Invest 1997, 99:2139-2151.
59. Hamai Y, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y: Evidence for bFGF as a crucial angiogenic growth factor, released from human trophoblasts during early gestation. Placenta 1998, 19:149-155.
60. Folkman J: Tumor angiogenesis. In Cancer Medicine (Edited by: Holland J). Baltimore: Williams and Wilkins 1997, 181-204.
61. Charnock-Jones DS, Sharkey AM, Rajput-Williams J, Burch D, Schofield JP, Fountain SA, Boocock CA, Smith SK: Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial cell lines. Biol Reprod 1993, 48:1120-1128.
62. Li XF, Gregory J, Ahmed A: Immunolocalization of VEGF in human endometrium. Growth Factors 1994, 11:277-282.
63. Clark DE, Smith SK, Sharkey AM, Charnock-Jones DS: Localization of VEGF and expression of its receptors flt and KDR (Kinase Domain Receptor) in human placenta throughout pregnancy. Hum Reprod 1996, 11:1090-1098.
64. Bischof P, Campana A: A putative role for oncogenes in trophoblast invasion? Hum Reprod 2000, 15:51-58.
65. Doneda L, Bulfamante G, Grimoldi MG, Volpi L, Larizza L: Localization of fos, jun, kit and SCF mRNA in human placenta throughout gestation using in situ RT-PCR. Early Pregnancy 1997, 3:265-271.
66. Muller R, Tremblay JM, Adamson ED, Verma IM: Tissue and cell type-specific expression of two human c-onc genes. Nature 1983, 304:454-456.
67. Dakour J, Li H, Chen H, Morrish DW: EGF promotes development of a differentiated trophoblast phenotype having c-myc and Jun B proto-oncogene activation. Placenta 1999, 20:119-126.
68. Kistner SM, Wang ZQ, Angel P, Wagner EF: Jun B is essential for mammalian placentation. EMBO J 1999, 18:934-948.
69. Horikawa I, Cable PL, Afsari C, Barrett JJ: Cloning and characterization of the promoter region of the hTERT gene. Cancer Res 1999, 59:826-830.
70. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R: Direct activation of TERT transcription by c-MYC. Nature Genet 1999, 21:220-224.
71. Pfeifer-Ohlsson SB, Goustin AS, Rydnert J, Wahlstrom T, Bjersing L, Stehelin D, Ohlsson R: Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation. Cell 1984, 38:585-596.
72. Goustin AS, Betsholtz C, Pfeifer-Ohlsson SP, Person H, Rydnert J, Bywater M, Holmgren G, Heldin CH, Westermark B, Ohlsson R: Co-expression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth. Cell 1985, 41:301-312.
73. Roncalli M, Bulfamante G, Viale G, Springall DR, Alfano R, Comi A, Maggioni M, Polak JM, Coggi G: c-myc and tumor suppressor gene product expression in developing and term human trophoblast. Placenta 1994, 15:399-409.
74. Osterlund C, Wramsby H, Poussete A: Temporal expression of PDGF-A and its receptor in human pre-implantation embryos. Mol Hum Reprod 1996, 2:507-512.
75. Jokhi PP, King A, Loke YW: Reciprocal expression of EGFR and c-erbB2 by non-invasive and invasive human trophoblast populations. Cytokine 1994, 6:433-442.
76. Yudoh K, Matsui H, Kanamori M, Maeda A, Ohmori K, Tsuji H: Effects of epidermal on invasiveness through the extracellular matrix in high growth and low factor metastatic clones of RCT sarcoma in vitro. Jpn J Cancer Res 1994, 85:63-71.
77. Lala PK, Hamilton GS: Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996, 17:545-555.
78. Hoffman GE, Scott Jr RT, Bergh PA: Immunochemical localization of EGF in human endometrium, decidua and placenta from early, mid and late gestation. Am J Obstet Gynecol 1991, 73:882-887.
79. Lysiak JJ, Johnson GR, Lala PK: Localization of amphiregullin in the human placenta and decidua throughout gestation: role in trophoblast growth. Placenta 1995, 16:359-366.
80. Li RH, Zhuang LZ: The effects of growth factors on human normal placental cytotrophoblast cell proliferation. Hum Reprod 1997, 12:830-834.
81. Filla MS, Kaul KL: Relative expression of EGFR in placental cytotrophoblasts and choriocarcinoma cell lines. Placenta 1997, 18:17-27.
82. Pollard JW, Bartocci A, Arceci R, Orlofsky A, Ladner MB, Stanley ER: Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 1987, 330:484-486.
83. Hoshina M, Hishio A, Bo M, Boime I, Mochizuki M: [The expression of the oncogene fms in human chorionic tissue]. Nippon Sanka Fujinka Gakkai Zasshi 1985, 37:2791-2798.
84. Jokhi PP, Chumbley G, King A, Gardner L, Loke YW: Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human utero-placental interface. Lab Invest 1993, 68:308-320.
85. Sharkey AM, Dellow K, Blayney M, Macnamee M, Charnock-Jones S, Smith SK: Stage-specific expression of cytokine and receptor messenger in human pre implantation embryos. Biol Reprod 1995, 53:974-981.
86. Athanassiades A, Hamilton GS, Lala PK: VEGF provides an autocrine signal for first-trimester extra-villous trophoblast cell proliferation [abstract]. Biol Reprod 1996, 54:130.
87. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS: VEGF, PlGF and their receptors in isolated human trophoblast. Placenta 1997, 18:657-665.
88. Pijnenborg R, Robertson WB, Brosens I, Dixon G: Trophoblast invasion and establishment of hemochorial placentation in man and laboratory animals. Placenta 1981, 2:71-92.
89. Shih IM, Kurman RJ: Molecular basis of Gestational Trophoblastic Diseases. Curr Mol Med 2002, 2:1-12.
90. Rama S, Suresh Y, Rao AJ: TGFβ1 induces multiple independent signals to regulate human trophoblastic differentiation: mechanistic insights. Mol Cell Endocrinol 2003, 206:123-136.
91. Shih IM, Kurman RJ: New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease. Verh Dtsch Ges Pathol 1997, 81:266-272.
92. Norwitz ER, Schust DJ, Fisher SJ: Implantation and the survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
93. Li HW, Tsao SW, Cheung AN: Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 2002, 23:20-31.
94. Ichikawa N, Zhai YL, Shiozawa T, Toki T, Noguchi H, Nikaido T, Fujii S: Immunohistochemical analysis of cell cycle regulatory gene products in normal trophoblast and placental site trophoblastic tumor. Int J Gynecol Pathol 1998, 17:235-240.
95. Coukos G, Makrigiannakis A, Chung J, Randall TC, Rubin SC, Benjamin I: Complete hydatidiform mole. A disease with a changing profile. J Reprod Med 1999, 44:698-704.
96. Twiggs LB, Okagaki T, Phillips GL, Stroemer JR, Adcock LL: Trophoblastic pseudotumor-evidence of malignant disease potential. Gynecol Oncol 1981, 12:238-248.
97. Shih IM, Kurman RJ: Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 1998, 22:1393-1403.
98. Benirschke K, Kaufmann P: Abortion, placentas of trisomies, and immunological considerations of recurrent reproductive failure. In Pathology of the Human Placenta 4 Edition (Edited by: Benirschke K, Kaufmann P). New York: Springer Verlag 2000, 685-717.
99. Cross JC: Trophoblast function in normal and pre-eclamptic pregnancy. Fet Mat Med Rev 1996, 8:57-66.
100. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky CH, Fisher SJ: VEGF ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe pre-eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002, 160:1405-1423.
101. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C: HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003, 59:219-34.
102. Anthony RV, Limesand SW, Jeckel KM: Transcriptional regulation in the placenta during normal and compromised fetal growth. Biochem Soc Trans 2001, 29:42-48.
103. van Lijnschoten G, Arends JW, Geraedts JP: Comparison of histological features in early spontaneous and induced trisomic abortions. Placenta 1994, 15:765-773.
104. Rao MR, Dharmarajan AM, Rao AJ: Cloning and characterization of an apoptosis-associated gene in the human placenta. Apoptosis 2000, 5:53-60.
105. Rama S, Rao AJ: Regulation of growth and function of the human placenta. Mol Cell Biochem 2003, 253:263-268.
106. Shi QJ, Lei ZM, Rao CV, Lin J: Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinol 1993, 132 1387-1395.